Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

NCT01402284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Lenalidomide

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]
[object Object]